Fundz

Daiichi Sankyo Names Hiroyuki Okuzawa as Chief Executive Officer (CEO) Succeeding Sunao Manabe

Jan 31, 2025

Position

Chief Executive Officer

Company

Daiichi Sankyo

Hiroyuki Okuzawa
hiroyuki.okuzawa@daiichisankyo.com
MunichBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Description

Daiichi Sankyo has announced the appointment of Hiroyuki Okuzawa as the new CEO, effective April 1, 2025, following a recommendation by the nomination committee to strengthen the management structure and achieve strategic goals. This leadership transition aligns with the company's preparations for the final year of its current five-year business plan in 2025, as well as its roadmap for the financial years 2026 (FY26) to FY30.

Who to call at Daiichi Sankyo, and when

A new leader at Daiichi Sankyo brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Daiichi Sankyo raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Daiichi Sankyo, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Daiichi Sankyo. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Daiichi Sankyo

Location

Munich, Bavaria, Germany

About

Daiichi Sankyo is a global pharmaceutical company that focuses on innovative and sustainable practices in the development of medicines. The company aims to contribute to the health of patients through its wide-ranging drug development portfolio, particularly in oncology. Additionally, AstraZeneca is a biopharmaceutical company that specializes in the development of medicines for various diseases, with a strong emphasis on oncology research. Both companies are working together to advance treatments for serious medical conditions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Daiichi Sankyo changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Hiroyuki
Likely contact at this company
••••••••@••••••••

See Hiroyuki's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Daiichi Sankyo's next move

Learn about Strategic plan

Daiichi Sankyo changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.